Fabry disease acute crisis
Inborn error · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
X-linked lysosomal storage disorder (alpha-galactosidase A deficiency) with episodic severe neuropathic pain crises (acroparaesthesiae) and multisystem (renal, cardiac, cerebrovascular) involvement.
Red flags
- Stroke / TIA symptoms
- Cardiac arrhythmia
- Progressive renal impairment
- Severe intractable pain
Assessment
Differential diagnosis
- Peripheral neuropathy (other)
- Erythromelalgia
- Vasculitis
- Sickle cell crisis
- Complex regional pain syndrome
Investigations
- Assess for triggers (fever, exertion, temperature change)
- Renal and cardiac assessment
- Alpha-galactosidase A activity / genetics (diagnosis)
- ECG and echocardiography
- Neuroimaging if stroke-like symptoms
Management
- Provide adequate analgesia for the pain crisis
- Identify and remove triggers
- Assess renal, cardiac and cerebrovascular status
- Refer to metabolic / specialist services
- Optimise enzyme replacement or chaperone therapy (specialist)
- Manage organ complications
Drugs & doses
Neuropathic pain agents / analgesia
Enzyme replacement therapy (specialist, chronic)
Organ-directed therapy
Disposition
Analgesia and specialist referral; admit if organ complication.
Complications & pitfalls
- Chronic kidney disease
- Cardiomyopathy / arrhythmia
- Stroke
- Chronic pain
Exam pearls
- Consider Fabry in a young person with unexplained neuropathic pain, stroke or proteinuria.
- It is a multisystem disease; assess heart, kidneys and brain.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.